Gossamer Bio Financials - Benzinga

Gossamer Bio Inc

GOSSNASDAQ

Trade with Public

Trade with Public

$0.1701

N/A

At close: Aug 28, 5:00 PM EST

$0.1715

0.00140.82%

After Hours: 7:57 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Gossamer Bio Financials

Gossamer Bio (GOSS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Gossamer Bio Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $9.238M Beat $5.193M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 33.33 percent. This is a 52.94 percent increase over losses of $(0.17) per share from the

Benzinga Newsdesk

PRO
Gossamer Bio Q1 EPS $(0.20) Misses $(0.13) Estimate, Sales $16.955M Beat $4.475M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.13) by 53.85 percent. This is a 25 percent decrease over losses of $(0.16) per share from the

Benzinga Newsdesk

PRO
Gossamer Bio Q4 EPS $(0.21) Misses $(0.18) Estimate, Sales $13.799M Beat $7.522M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 14.13 percent. This is a 40 percent decrease over losses of $(0.15) per share from the

Benzinga Newsdesk

PRO
Gossamer Bio Q3 EPS $(0.21) Misses $(0.18) Estimate, Sales $13.294M

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 16.02 percent. This is a 50 percent decrease over losses of $(0.14) per share from the

Benzinga Newsdesk

PRO
Gossamer Bio Q2 EPS $(0.17) Beats $(0.18) Estimate, Sales $11.49M Beat $4.34M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.03 percent. This is a 177.27 percent decrease over earnings of $0.22 per share from the

Benzinga Newsdesk

PRO
Gossamer Bio Q1 EPS $(0.16) Beats $(0.18) Estimate, Sales $9.89M Beat $4.07M Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 15.79 percent increase over losses of $(0.19) per share from the

Benzinga Newsdesk